Explorium Logo

dyGenesys Bio-technologies, LLC logo

dygenesys.com

629 Fifth Avenue Pelham, NY 10803, US

dyGenesys Bio-technologies, LLC

dyGenesys Bio-Technologies, LLC (dyGenesys) is a Joint Venture between DalinYebo Trading and Development (Pty) Ltd, a South African corporation trading in bio-based or biodegradable chemicals and developing application to manufacture and/or use furfural and its many byproducts and Genesys Engineering P.C., a New York professional corporation, who understand the need for integration of hands-on plant engineering expertise with the practice of consulting engineering: - Electrical Power - Furfural Manufacturing - Furfural Trade and Applications From their 629 Fifth Avenue, Pelham, NY 10803, offices, dyGenesys provides know-how and implements projects in the USA (NAFTA region) on the basis of bioresources conversion technologies such as SupraYield and electrical power generation.

dyGenesys Bio-technologies, LLC logo

dyGenesys Bio-technologies, LLC

dyGenesys Bio-Technologies, LLC (dyGenesys) is a Joint Venture between DalinYebo Trading and Development (Pty) Ltd, a South African corporation trading in bio-based or biodegradable chemicals and developing application to manufacture and/or use furfural and its many byproducts and Genesys Engineering P.C., a New York professional corporation, who understand the need for integration of hands-on plant engineering expertise with the practice of consulting engineering: - Electrical Power - Furfural Manufacturing - Furfural Trade and Applications From their 629 Fifth Avenue, Pelham, NY 10803, offices, dyGenesys provides know-how and implements projects in the USA (NAFTA region) on the basis of bioresources conversion technologies such as SupraYield and electrical power generation.

dygenesys.com

629 Fifth Avenue Pelham, NY 10803, US

Details

Year founded

2008

Revenue

500K-1M

Employees

1-10

Number of locations

1

NAICS

325

SIC

2869

Products & Services

Outlines the company's specialized services and operational strengths.

  • Cell and Gene Therapies
  • DNA Synthesizers
  • Gene Synthesis
  • Contact us in order to access

Equipment

Provides a detailed list of machinery and tools utilized on the company's premises.

  • Industrial fixture
  • Device
  • Support facilities
  • Contact us in order to access

Ramping up production

Indicates the company's current production trend and growth trajectory.

FALSE

Our production algorithm is showing that dygenesys bio technologies is not ramping up production.

Target industries

Manufacturing
Machinery Manufacturing
Industrial
Book a demo

Locations (1)

dyGenesys Bio-technologies, LLC

629 Fifth Avenue Pelham, NY 10803, US

Frequently Asked Questions


dyGenesys Bio-technologies, LLC offers a range of services and capabilities, including Cell and Gene Therapies.


Get the full services & capabilities list of dyGenesys Bio-technologies, LLC

dyGenesys Bio-technologies, LLC uses a variety of equipment, including Industrial fixture.


Get the full equipment list of dyGenesys Bio-technologies, LLC

dyGenesys Bio-technologies, LLC serves several industries, including the manufacturing industry.


Get the full target industries list of dyGenesys Bio-technologies, LLC

dyGenesys Bio-technologies, LLC operates from a single location at 629 fifth avenue, pelham, new york 10803, united states.


Get a free locations and target markets review for dyGenesys Bio-technologies, LLC

The headquarters of dyGenesys Bio-technologies, LLC are located in 629 fifth avenue, pelham, new york 10803, united states.


Get a free locations and target markets review for dyGenesys Bio-technologies, LLC

The NAICS code for dyGenesys Bio-technologies, LLC is 325.


Get a free business data review for dyGenesys Bio-technologies, LLC

dyGenesys Bio-technologies, LLC has an employee count in the range of 1-10 employees.


Get a free workforce data review of dyGenesys Bio-technologies, LLC

The official website of dyGenesys Bio-technologies, LLC is https://www.dygenesys.com/.


dyGenesys Bio-technologies, LLC was founded in 2008.